BioCentury | Dec 6, 2019
Targets & Mechanisms

Emerging immuno-oncology mechanisms at ASH 2019

...purine salvage pathway were a synthetic lethal pair with PAICS . A separate group from Kumamoto University...
...high mobility group box Allison Johnson, Senior Writer Inarigivir soproxil (sb 9200) American Society of Hematology Northwestern University University Health Network Kumamoto University Harvard...
BioCentury | Apr 10, 2019
Tools & Techniques

Microbiome makes its mark outside the gut

...could help predict prognosis and the density of anti-tumor T cells at the metastasis site. Kumamoto University...
BioCentury | Feb 22, 2017
Distillery Techniques

Drug delivery

...published online Jan. 14, 2017 doi:10.1016/j.xphs.2017.01.002 CONTACT: H. Arima, Kumamoto University, Kumamoto, Japan email: arimah@gpo.kumamoto-u.ac.jp Hongjiang Li Lucentis Synagis Vectibix Xolair Kumamoto University Fc...
BioCentury | May 1, 2014
Distillery Therapeutics

Indication: Hepatic disease

...Yoshizawa, T. et al. Cell Metab.; published online April 1, 2014; doi:10.1016/j.cmet.2014.03.006 Contact: Kazuya Yamagata, Kumamoto University...
BioCentury | Jan 16, 2014
Distillery Techniques

Technology: Drug platforms

...A. et al. Cell Stem Cell; published online Dec. 12, 2013; doi:10.1016/j.stem.2013.11.010 Contact: Ryuichi Nishinakamura, Kumamoto University...
BioCentury | Jul 30, 2012
Company News

Merck, Yamasa deal

...is eligible for milestones. The compound was discovered by researchers led by Hiroaki Mitsuya at Kumamoto University's...
BioCentury | Jul 25, 2012
Company News

Merck announces HIV deals with Chimerix, Yamasa

...is eligible for milestones. The compound was discovered by researchers led by Hiroaki Mitsuya at Kumamoto University's...
BioCentury | Nov 17, 2011
Distillery Therapeutics

Indication: Cancer

...Aoi, J. et al. Cancer Res.; published online Oct. 31, 2011; doi:10.1158/0008-5472.CAN-11-1758 Contact: Yuichi Oike, Kumamoto University...
BioCentury | Nov 4, 2010
Distillery Therapeutics

Indication: Inflammation

...N. et al. J. Med. Chem.; published online Oct. 18, 2010; doi:10.1021/jm101116s Contact: Tohru Mizushima, Kumamoto University...
BioCentury | Sep 3, 2009
Distillery Therapeutics

Indication: Endocrine disease

...Tabata, M. et al. Cell Metab.; published online Sept. 1, 2009; doi:10.1016/j.cmet.2009.08.003 Contact: Yuichi Oike, Kumamoto University...
Items per page:
1 - 10 of 10
BioCentury | Dec 6, 2019
Targets & Mechanisms

Emerging immuno-oncology mechanisms at ASH 2019

...purine salvage pathway were a synthetic lethal pair with PAICS . A separate group from Kumamoto University...
...high mobility group box Allison Johnson, Senior Writer Inarigivir soproxil (sb 9200) American Society of Hematology Northwestern University University Health Network Kumamoto University Harvard...
BioCentury | Apr 10, 2019
Tools & Techniques

Microbiome makes its mark outside the gut

...could help predict prognosis and the density of anti-tumor T cells at the metastasis site. Kumamoto University...
BioCentury | Feb 22, 2017
Distillery Techniques

Drug delivery

...published online Jan. 14, 2017 doi:10.1016/j.xphs.2017.01.002 CONTACT: H. Arima, Kumamoto University, Kumamoto, Japan email: arimah@gpo.kumamoto-u.ac.jp Hongjiang Li Lucentis Synagis Vectibix Xolair Kumamoto University Fc...
BioCentury | May 1, 2014
Distillery Therapeutics

Indication: Hepatic disease

...Yoshizawa, T. et al. Cell Metab.; published online April 1, 2014; doi:10.1016/j.cmet.2014.03.006 Contact: Kazuya Yamagata, Kumamoto University...
BioCentury | Jan 16, 2014
Distillery Techniques

Technology: Drug platforms

...A. et al. Cell Stem Cell; published online Dec. 12, 2013; doi:10.1016/j.stem.2013.11.010 Contact: Ryuichi Nishinakamura, Kumamoto University...
BioCentury | Jul 30, 2012
Company News

Merck, Yamasa deal

...is eligible for milestones. The compound was discovered by researchers led by Hiroaki Mitsuya at Kumamoto University's...
BioCentury | Jul 25, 2012
Company News

Merck announces HIV deals with Chimerix, Yamasa

...is eligible for milestones. The compound was discovered by researchers led by Hiroaki Mitsuya at Kumamoto University's...
BioCentury | Nov 17, 2011
Distillery Therapeutics

Indication: Cancer

...Aoi, J. et al. Cancer Res.; published online Oct. 31, 2011; doi:10.1158/0008-5472.CAN-11-1758 Contact: Yuichi Oike, Kumamoto University...
BioCentury | Nov 4, 2010
Distillery Therapeutics

Indication: Inflammation

...N. et al. J. Med. Chem.; published online Oct. 18, 2010; doi:10.1021/jm101116s Contact: Tohru Mizushima, Kumamoto University...
BioCentury | Sep 3, 2009
Distillery Therapeutics

Indication: Endocrine disease

...Tabata, M. et al. Cell Metab.; published online Sept. 1, 2009; doi:10.1016/j.cmet.2009.08.003 Contact: Yuichi Oike, Kumamoto University...
Items per page:
1 - 10 of 10